oral erythroplakia
Conditions
Interventions
photodynamic therapy:NA
Sponsors
Hospital of Stomatology Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with oral erythroplakia who sought treatment at the Oral Disease Department of Wuhan University School of Stomatology from November 2019 to April 2024, with clinical manifestations that meet the definition of oral erythroplakia set forth in the "Expert Consensus on Clinical Diagnosis and Treatment of Oral Erythroplakia" issued by the Chinese Stomatological Association in 2023, including the following: A) Clinical manifestations of homogeneous and heterogeneous erythema lesions. Homogeneous lesions are characterized by soft, smooth, velvety bright red surfaces with well-defined margins. Heterogeneous lesions are characterized by red patches scattered within the lesion area, with red and white patches alternating. B) Histopathological findings that exclude other definable diseases, characterized by marked epithelial atrophy, accompanied by varying degrees of epithelial dysplasia, consistent with the diagnosis of oral erythroplakia. 2.Patients aged 18 to 80 years old; 3.Patients received and completed at least one session of photodynamic therapy; 4.Regular follow-up more than 3 months;
Exclusion criteria
Exclusion criteria: 1.The initial pathological results of the patients showed carcinoma in situ or invasive carcinoma; 2.Clinical follow-up records or information is not complete;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrence rate;malignant transformation rate;efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse effects rate; | — |
Countries
China
Contacts
Public ContactLu Rui
Hospital of Stomatology Wuhan University
Outcome results
None listed